Top DoD in-vitro diagnostic substance manufacturing contractors (NAICS 325413)
- Latest 12 months
- $49.6M
- Net obligations · Up $334.0K vs. $49.2M preceding
- Prime contractors
- 101
- With positive obligations in the latest 12 months
Research the DoD federal contracting market for in-vitro diagnostic substance manufacturing under NAICS 325413. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, and contract types, competition, and procurement methods.
Contract obligation trends for In-Vitro Diagnostic Substance Manufacturing at the Department of Defense
Federal records show $5.4B in net obligations across 3,521 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Defense from Oct 1, 2021 through Sep 10, 2026. This market accounts for 0.24% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 0.7% from $49.2M to $49.6M. 21 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $4.8B | 1,660 | Complete |
| FY2023 | $547.3M | 1,330 | Complete |
| FY2024 | $50.3M | 1,253 | Complete |
| FY2025 | $48.8M | 1,323 | Complete |
| FY2026 | $47.8M | 733 | YTD through Sep 10, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $5.4B
- 3,521 awards · 220 prime contractors
- Latest 12-month movement
- +0.7%
- $49.6M vs. $49.2M
- Leading eight prime share
- 49.0%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.24% of $2.3T in agency-wide net obligations.
- Set-aside share when reported
- 2.4% of 2,267 awards with reported set-aside status.
- Set-aside reporting
- 55 set aside · 2,212 no set-aside · 1,254 not reported
What changed in the last 12 months?
Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.
Competitive shifts
HOLOGIC, INC. fell the most in the contractor rankings
ORTHO-CLINICAL DIAGNOSTICS, INC lost the most market share
Buyer demand
Reported obligations through AMC MADIGAN LEWIS - MM increased
Reported obligations through AMC BRAGG - MM decreased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.
17.9% of positive obligations were attributed to AMC BAMC FSH - MM. That represents $8.9M, up $13.4M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- AMC BAMC FSH - MM17.9% · $8.9M · up $13.4M
- AMC MADIGAN LEWIS - MM10.0% · $5.0M · up $3.4M
- AMC TRIPLER SHAFTER - MM6.7% · $3.3M · down $769K
- AMC BEAUMONT BLISS - MM5.0% · $2.5M · up $556K
- ACH BENNING - MM4.4% · $2.2M · up $278K
- All other reported offices56.0% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
AMC BAMC FSH - MM
#1New to the positive-obligation rankingLatest 12 months
$8.9M
17.9% of positive obligations
Versus preceding 12 months
+$13.4M
21 active prime contractors · 24 awards
View office comparison and evidence
Reported obligations moved from $4.6M in net deobligations to $8.9M in net obligations. The office’s share of positive obligations moved from 0% to 17.9%, a change of +17.9 percentage points.
The latest period contains 62 actions across 24 awards and 2 newly active prime contractors. The preceding period contained 22 active prime contractors and 34 awards.
Leading award-level changes
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0025FA207+$1.7M: $0 → $1.7M
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0020P0371+$1.7M: −$1.7M → $0
Reported funding office
AMC MADIGAN LEWIS - MM
#2Up 9 from #11Latest 12 months
$5.0M
10.0% of positive obligations
Versus preceding 12 months
+$3.4M
16 active prime contractors · 26 awards
View office comparison and evidence
Reported obligations increased 213.1% from $1.6M to $5.0M. The office’s share of positive obligations moved from 2.9% to 10.0%, a change of +7.1 percentage points.
The latest period contains 66 actions across 26 awards and 9 newly active prime contractors. The preceding period contained 10 active prime contractors and 13 awards.
Reported funding office
AMC TRIPLER SHAFTER - MM
#3Down 1 from #2Latest 12 months
$3.3M
6.7% of positive obligations
Versus preceding 12 months
−$769K
12 active prime contractors · 12 awards
View office comparison and evidence
Reported obligations decreased 18.8% from $4.1M to $3.3M. The office’s share of positive obligations moved from 7.5% to 6.7%, a change of −0.8 percentage points.
The latest period contains 38 actions across 12 awards and 2 newly active prime contractors. The preceding period contained 15 active prime contractors and 21 awards.
Reported funding office
AMC BEAUMONT BLISS - MM
#4Up 4 from #8Latest 12 months
$2.5M
5.0% of positive obligations
Versus preceding 12 months
+$556K
7 active prime contractors · 8 awards
View office comparison and evidence
Reported obligations increased 29.2% from $1.9M to $2.5M. The office’s share of positive obligations moved from 3.5% to 5.0%, a change of +1.4 percentage points.
The latest period contains 14 actions across 8 awards and 1 newly active prime contractor. The preceding period contained 9 active prime contractors and 10 awards.
Reported funding office
ACH BENNING - MM
#5Up 4 from #9Latest 12 months
$2.2M
4.4% of positive obligations
Versus preceding 12 months
+$278K
7 active prime contractors · 8 awards
View office comparison and evidence
Reported obligations increased 14.6% from $1.9M to $2.2M. The office’s share of positive obligations moved from 3.5% to 4.4%, a change of +0.9 percentage points.
The latest period contains 15 actions across 8 awards. The preceding period contained 11 active prime contractors and 16 awards.
Reported funding office
LANDSTUHL RMC - MM
#6Up 6 from #12Latest 12 months
$2.1M
4.3% of positive obligations
Versus preceding 12 months
+$660K
6 active prime contractors · 8 awards
View office comparison and evidence
Reported obligations increased 45.0% from $1.5M to $2.1M. The office’s share of positive obligations moved from 2.7% to 4.3%, a change of +1.6 percentage points.
The latest period contains 25 actions across 8 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 11 awards.
Reported funding office
AHC MONCRIEF JACKSON - MM
#7Up 9 from #16Latest 12 months
$1.6M
3.2% of positive obligations
Versus preceding 12 months
+$584K
5 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations increased 58.4% from $999K to $1.6M. The office’s share of positive obligations moved from 1.8% to 3.2%, a change of +1.4 percentage points.
The latest period contains 9 actions across 5 awards. The preceding period contained 5 active prime contractors and 5 awards.
Reported funding office
ACH BRIAN ALLGOOD - PA
#8Up 2 from #10Latest 12 months
$1.5M
3.0% of positive obligations
Versus preceding 12 months
−$235K
11 active prime contractors · 15 awards
View office comparison and evidence
Reported obligations decreased 13.6% from $1.7M to $1.5M. The office’s share of positive obligations moved from 3.2% to 3.0%, a change of −0.2 percentage points.
The latest period contains 43 actions across 15 awards and 1 newly active prime contractor. The preceding period contained 14 active prime contractors and 26 awards.
Reported funding office
88TH MDSS SGSL - PA
#9Down 6 from #3Latest 12 months
$1.4M
2.9% of positive obligations
Versus preceding 12 months
−$1.5M
6 active prime contractors · 19 awards
View office comparison and evidence
Reported obligations decreased 51.6% from $3.0M to $1.4M. The office’s share of positive obligations moved from 5.5% to 2.9%, a change of −2.6 percentage points.
The latest period contains 19 actions across 19 awards. The preceding period contained 6 active prime contractors and 24 awards.
Reported funding office
AMC GORDON - PA
#10Up 5 from #15Latest 12 months
$1.4M
2.8% of positive obligations
Versus preceding 12 months
+$263K
6 active prime contractors · 6 awards
View office comparison and evidence
Reported obligations increased 23.6% from $1.1M to $1.4M. The office’s share of positive obligations moved from 2.0% to 2.8%, a change of +0.7 percentage points.
The latest period contains 9 actions across 6 awards. The preceding period contained 7 active prime contractors and 8 awards.
Reported funding office
AMC BRAGG - MM
#18Down 13 from #5Latest 12 months
$837K
1.7% of positive obligations
Versus preceding 12 months
−$1.7M
2 active prime contractors · 2 awards
View office comparison and evidence
Reported obligations decreased 66.6% from $2.5M to $837K. The office’s share of positive obligations moved from 4.6% to 1.7%, a change of −2.9 percentage points.
The latest period contains 4 actions across 2 awards. The preceding period contained 4 active prime contractors and 5 awards.
Reported funding office
W40M MRC0 WEST
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$4.8M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $4.8M to $0. The office’s share of positive obligations moved from 8.9% to 0%, a change of −8.9 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 14 active prime contractors and 15 awards.
Leading award-level changes
- BIOFIRE DIAGNOSTICS LLC · PIID W81K0020P0348−$933K: $933K → $0
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0023P0198−$841K: $841K → $0
Reported funding office
W2DN BROOKE AMC
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$2.4M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $2.4M to $0. The office’s share of positive obligations moved from 4.5% to 0%, a change of −4.5 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 3 awards.
Reported funding office
AMC BEAUMONT BLISS - PB
No positive-obligation rankLatest 12 months
−$20K
0% of positive obligations
Versus preceding 12 months
−$2.2M
3 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations moved from $2.2M in net obligations to $20K in net deobligations. The office’s share of positive obligations moved from 4.0% to 0%, a change of −4.0 percentage points.
The latest period contains 3 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 6 awards.
Contract types, competition, and procurement methods
From Sep 11, 2025 through Sep 10, 2026, 473 awards had positive obligations totaling $50.6M. Simplified Acquisition was the leading reported procedure, accounting for 75.7% of positive obligations. Awards with a reported parent IDV accounted for 38.8%.
- Leading award type
- 49.0%
- Purchase Order
- Leading reported procedure
- 75.7%
- Simplified Acquisition
- Reported parent IDV
- 38.8%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 379 of 473 awards reported offers
Buying method changes
Compared with Sep 11, 2024–Sep 10, 2025. Based on 473 current awards and 819 preceding awards with positive net obligations.
- Median positive award obligations
- $31K
- Up from $13K in the preceding period
- Delivery-order obligation share
- 28.6%
- Up from 18.5% in the preceding period
How to read these changes
Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.
Same-NAICS comparison
Compared with the NAICS 325413 peer median, parent-IDV obligation share is 39.2 percentage points lower, reported full-and-open obligation share is 6.7 percentage points lower, delivery-order obligation share is 14.8 percentage points lower, and median positive award obligations are 35.9% lower.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 38.8% | 77.9% | -39.2 pts |
| Reported full-and-open obligation share | 9.8% | 16.5% | -6.7 pts |
| Delivery-order obligation share | 28.6% | 43.4% | -14.8 pts |
| Median positive award obligations | $31K | $49K | -35.9% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Agriculture (USDA)
- Department of Health and Human Services (HHS)
- Department of Veterans Affairs (VA)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Purchase Order(B) | 276 | $24.8M | 49.0% |
| Delivery Order(C) | 103 | $14.5M | 28.6% |
| Definitive Contract(D) | 21 | $6.2M | 12.3% |
| BPA Call(A) | 73 | $5.1M | 10.1% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 94 | $14.2M | 28.0% |
| BPA(E) | 73 | $5.1M | 10.1% |
| FSS(C) | 9 | $327K | 0.65% |
| Not reported | 297 | $31.0M | 61.3% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 167 | $19.3M | 38.1% |
| Multiple Award(M) | 9 | $327K | 0.65% |
| Not reported | 297 | $31.0M | 61.3% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Simplified Acquisition(SP1) | 407 | $38.3M | 75.7% |
| Only One Source(SSS) | 36 | $7.2M | 14.2% |
| Negotiated Proposal/Quote(NP) | 17 | $4.7M | 9.4% |
| Subject to Multiple Award Fair Opportunity(MAFO) | 9 | $327K | 0.65% |
| Sp1(SIMPLIFIED ACQUISITION) | 4 | $70K | 0.14% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Competed Under SAP(F) | 284 | $21.2M | 41.9% |
| Not Competed Under SAP(G) | 123 | $17.1M | 33.7% |
| Not Competed(C) | 36 | $7.2M | 14.2% |
| Full and Open Competition(A) | 25 | $4.9M | 9.8% |
| Full and Open Competition After Exclusion of Sources(D) | 1 | $117K | 0.23% |
| G(NOT COMPETED UNDER SAP) | 2 | $68K | 0.14% |
| Other reported values | 2 | $1K | 0.0025% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 6 | $203K | 0.40% |
| Fair Opportunity Given(FAIR) | 3 | $124K | 0.25% |
| Not reported | 464 | $50.2M | 99.4% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SAP Non-Competition (FAR 13)(SP2) | 122 | $14.7M | 29.1% |
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 33 | $7.0M | 13.9% |
| Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH) | 3 | $2.4M | 4.7% |
| Brand Name Description (FAR 6.302-1(C))(BND) | 3 | $191K | 0.38% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 1 | $73K | 0.14% |
| Not reported | 311 | $26.1M | 51.7% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 469 | $50.5M | 99.9% |
| J(FIRM FIXED PRICE) | 4 | $70K | 0.14% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550) | 370 | $37.0M | 73.3% |
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 37 | $5.0M | 9.8% |
| Drugs and Biologicals(6505) | 14 | $4.5M | 8.8% |
| Laboratory Equipment and Supplies(6640) | 26 | $1.9M | 3.7% |
| Lease or Rental of Equipment- Medical, Dental, and Veterinary Equipment and Supplies(W065) | 2 | $562K | 1.1% |
| Chemical Analysis Instruments(6630) | 2 | $527K | 1.0% |
| Other reported values | 22 | $1.1M | 2.2% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of the Army(2100) | 133 | $27.0M | 53.4% |
| Defense Health Agency(97DH) | 142 | $18.8M | 37.2% |
| Department of the Air Force(5700) | 32 | $2.1M | 4.2% |
| Defense Logistics Agency(97AS) | 133 | $1.4M | 2.8% |
| Department of the Navy(1700) | 33 | $1.2M | 2.3% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| W40m Mrc0 West(W81K00) | 78 | $20.3M | 40.2% |
| Defense Health Agency Hcd West(HT9410) | 58 | $10.4M | 20.6% |
| Defense Health Agency(HT9406) | 21 | $3.6M | 7.1% |
| W40m Mrco Pacific(W81K02) | 23 | $3.1M | 6.1% |
| W40m Usa Hca(W81K04) | 23 | $1.9M | 3.8% |
| W40m Mrco East(W91YTZ) | 9 | $1.7M | 3.3% |
| Other reported values | 261 | $9.5M | 18.8% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| W81K0225DA021(9700) | 1 | $1.9M | 3.9% |
| W81K0025DA002(9700) | 1 | $1.7M | 3.4% |
| W9114F24D0005(9700) | 3 | $1.6M | 3.2% |
| SPE8EQ25D0004(9700) | 9 | $1.3M | 2.6% |
| W81K0023D0005(9700) | 1 | $1.1M | 2.1% |
| W81K0225DA010(9700) | 1 | $968K | 1.9% |
| HT001425A0006(9700) | 1 | $868K | 1.7% |
| N6264523D5013(9700) | 6 | $721K | 1.4% |
| Other reported values | 153 | $9.4M | 18.5% |
| Not reported | 297 | $31.0M | 61.3% |
Offers, award size, and timing
- Median reported offers
- 1 median
- 379 reported · 94 not reported
- Positive award obligations
- $31K median
- $3K–$97K middle 50%
- Reported performance period
- 208 days (~7 months) median
- 472 reported · 1 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 21 of 101prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 15.3%of positive obligations in the last 12 months
- Leading four prime contractors
- 31.9%of positive obligations in the last 12 months
- Leading eight prime contractors
- 49.0%of positive obligations in the last 12 months
Based on $50.1M in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$7.7M
15.3%
Dollar movement
−$138K
vs. prior 12 months
Last 12mo awards
21 awards
49 actions
Historical and award details for ROCHE DIAGNOSTICS CORPORATION
- Obligations: prior → latest
- $7.8M → $7.7M
- −1.8%
- Share: prior → latest
- 15.8% → 15.3%
- −0.5 percentage points
- All-period obligations
- $610.9M
- 11.2% of all-period positive obligations · 69 awards
- Recorded activity
- Since Oct 4, 2021
- through Apr 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 17 31 Not reported 4 5 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$3.5M
7.0%
Dollar movement
−$327K
vs. prior 12 months
Last 12mo awards
15 awards
26 actions
Historical and award details for HOLOGIC SALES AND SERVICE, LLC
- Obligations: prior → latest
- $3.8M → $3.5M
- −8.6%
- Share: prior → latest
- 7.7% → 7.0%
- −0.8 percentage points
- All-period obligations
- $14.6M
- 0.27% of all-period positive obligations · 51 awards
- Recorded activity
- Since Oct 6, 2021
- through Apr 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 15 23 Not reported 0 1 Reported small business 0 1 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$2.5M
5.0%
Dollar movement
+$934K
vs. prior 12 months
Last 12mo awards
17 awards
30 actions
Historical and award details for BECKMAN COULTER, INC
- Obligations: prior → latest
- $1.6M → $2.5M
- +58.6%
- Share: prior → latest
- 3.2% → 5.0%
- +1.8 percentage points
- All-period obligations
- $9.7M
- 0.18% of all-period positive obligations · 52 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 17 26 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$2.3M
4.6%
Dollar movement
+$1.2M
vs. prior 12 months
Last 12mo awards
12 awards
20 actions
Historical and award details for DIASORIN INC
- Obligations: prior → latest
- $1.1M → $2.3M
- +104.6%
- Share: prior → latest
- 2.3% → 4.6%
- +2.3 percentage points
- All-period obligations
- $5.3M
- 0.10% of all-period positive obligations · 28 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 10 13 Not reported 2 0 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$2.2M
4.5%
Dollar movement
+$2.2M
vs. prior 12 months
Last 12mo awards
19 awards
36 actions
Historical and award details for QUIDELORTHO SALES COMPANY, LLC
- Obligations: prior → latest
- $2K → $2.2M
- +111502.7%
- Share: prior → latest
- 0% → 4.5%
- +4.5 percentage points
- All-period obligations
- $2.2M
- 0.040% of all-period positive obligations · 20 awards
- Recorded activity
- Since Jul 17, 2025
- through Apr 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 3 Not reported 6 1 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$2.2M
4.4%
Dollar movement
+$1.4M
vs. prior 12 months
Last 12mo awards
5 awards
11 actions
Historical and award details for CEPHEID
- Obligations: prior → latest
- $783K → $2.2M
- +180.0%
- Share: prior → latest
- 1.6% → 4.4%
- +2.8 percentage points
- All-period obligations
- $9.5M
- 0.17% of all-period positive obligations · 23 awards
- Recorded activity
- Since Oct 13, 2021
- through Apr 6, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 6 Not reported 2 3 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$2.2M
4.3%
Dollar movement
+$507K
vs. prior 12 months
Last 12mo awards
4 awards
11 actions
Historical and award details for BIOFIRE DEFENSE LLC
- Obligations: prior → latest
- $1.7M → $2.2M
- +30.7%
- Share: prior → latest
- 3.3% → 4.3%
- +1.0 percentage points
- All-period obligations
- $8.1M
- 0.15% of all-period positive obligations · 21 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 4 Not reported 1 0 Reported small business 2 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$2.0M
3.9%
Dollar movement
−$555K
vs. prior 12 months
Last 12mo awards
18 awards
26 actions
Historical and award details for ABBOTT LABORATORIES INC.
- Obligations: prior → latest
- $2.5M → $2.0M
- −22.2%
- Share: prior → latest
- 5.1% → 3.9%
- −1.2 percentage points
- All-period obligations
- $14.3M
- 0.26% of all-period positive obligations · 69 awards
- Recorded activity
- Since Oct 14, 2021
- through Apr 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 18 24 Not reported 0 1 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$1.8M
3.7%
Dollar movement
−$1.0M
vs. prior 12 months
Last 12mo awards
27 awards
38 actions
Historical and award details for SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Obligations: prior → latest
- $2.9M → $1.8M
- −35.8%
- Share: prior → latest
- 5.8% → 3.7%
- −2.1 percentage points
- All-period obligations
- $609.7M
- 11.2% of all-period positive obligations · 277 awards
- Recorded activity
- Since Oct 4, 2021
- through Apr 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 10 13 Not reported 17 50 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$1.8M
3.6%
Dollar movement
+$57K
vs. prior 12 months
Last 12mo awards
12 awards
25 actions
Historical and award details for SYSMEX AMERICA, INC
- Obligations: prior → latest
- $1.8M → $1.8M
- +3.3%
- Share: prior → latest
- 3.6% → 3.6%
- +0.1 percentage points
- All-period obligations
- $7.9M
- 0.14% of all-period positive obligations · 26 awards
- Recorded activity
- Since Oct 12, 2021
- through Apr 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 12 16 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$1.7M
3.3%
Dollar movement
+$1.7M
vs. prior 12 months
Last 12mo awards
2 awards
3 actions
Historical and award details for ABBOTT MOLECULAR INC.
- Obligations: prior → latest
- $0 → $1.7M
- Not comparable
- Share: prior → latest
- 0% → 3.3%
- +3.3 percentage points
- All-period obligations
- $1.8M
- 0.030% of all-period positive obligations · 5 awards
- Recorded activity
- Since Feb 3, 2022
- through Feb 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$1.6M
3.2%
Dollar movement
+$510K
vs. prior 12 months
Last 12mo awards
4 awards
13 actions
Historical and award details for BECKMAN COULTER GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG
- Obligations: prior → latest
- $1.1M → $1.6M
- +46.4%
- Share: prior → latest
- 2.2% → 3.2%
- +1.0 percentage points
- All-period obligations
- $2.7M
- 0.050% of all-period positive obligations · 5 awards
- Recorded activity
- Since Sep 26, 2024
- through Mar 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 4 5 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$1.3M
2.6%
Dollar movement
+$786K
vs. prior 12 months
Last 12mo awards
22 awards
41 actions
Historical and award details for WERFEN USA LLC
- Obligations: prior → latest
- $509K → $1.3M
- +154.5%
- Share: prior → latest
- 1.0% → 2.6%
- +1.6 percentage points
- All-period obligations
- $2.5M
- 0.050% of all-period positive obligations · 44 awards
- Recorded activity
- Since Oct 13, 2021
- through Apr 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 16 Not reported 9 11 Reported small business 4 5 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$1.3M
2.6%
Dollar movement
+$546K
vs. prior 12 months
Last 12mo awards
10 awards
11 actions
Historical and award details for SUMMIT SHOJI INC.
- Obligations: prior → latest
- $748K → $1.3M
- +73.0%
- Share: prior → latest
- 1.5% → 2.6%
- +1.1 percentage points
- All-period obligations
- $4.6M
- 0.080% of all-period positive obligations · 63 awards
- Recorded activity
- Since Jan 12, 2022
- through Apr 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 10 11 Reported small business 0 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$1.2M
2.3%
Dollar movement
+$966K
vs. prior 12 months
Last 12mo awards
3 awards
7 actions
Historical and award details for BIO RAD LABORATORIES INC
- Obligations: prior → latest
- $184K → $1.2M
- +524.3%
- Share: prior → latest
- 0.37% → 2.3%
- +1.9 percentage points
- All-period obligations
- $4.3M
- 0.080% of all-period positive obligations · 8 awards
- Recorded activity
- Since Oct 18, 2021
- through Feb 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 4 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$1.5M
BECKMAN COULTER, INC
ACH BENNING - MM
RELEASE OF FY26 FUNDS
Why it stands out
The contractor climbed 5 positions in this market.
It now ranks #3 by positive obligations over the latest 12 months.
- Award net obligations
- $1.5M
- Share of 12-month positive obligations
- 3.0%
Supporting data
- Prime contractor
- #3 · 5.0% share
- up 5 ranks · +1.8 percentage points · $934K net increase; action exceeded it by $559K
This action
+$1.5M
ABBOTT MOLECULAR INC.
AMC BAMC FSH - MM
FOR MOLECULAR TRANSPLANT, RESPIRATORY, AND SEXUAL HEALTH TESTING DEPARTMENT OF PATHOLOGY AND AREA LABORATORY SERVICES
Why it stands out
The award grew alongside stronger contractor activity.
The modification added $1.5M while contractor obligations rose $1.7M overall.
- Award net obligations
- $1.5M
- Share of 12-month positive obligations
- 3.0%
Supporting data
- Prime contractor
- #11 · 3.3% share
- +3.3 percentage points · $1.7M net increase; action accounted for 91.5%
This action
+$1.9M
ROCHE DIAGNOSTICS CORPORATION
AMC MADIGAN LEWIS - MM
REAGENTS, SUPPLIES, TRAINING AND MAINTENANCE FOR THE GOVERNMENT OWNED ROCHE DIAGNOSTIC TOTAL LABORATORY AUTOMATION SYSTEM.
Why it stands out
The award grew alongside stronger office-attributed spending.
The modification added $1.9M while office-attributed obligations rose $3.4M overall.
- Award net obligations
- $1.9M
- Share of 12-month positive obligations
- 3.9%
Supporting data
- Prime contractor
- #1 · 15.3% share
- $138K net decline despite this positive action
- Funding office
- #2 · 10.0% attributed share
- up 9 ranks · +7.1 percentage points · $3.4M net increase; action accounted for 57.7%
This action
+$1.4M
CEPHEID
AMC BAMC FSH - MM
FY26 COVID AND STREP TESTING. REAL TIME POLYMER CHAIN REACTION (RT-PCR) ANALYZERS FOR BROOKE ARMY MEDICAL CENTER
Why it stands out
The contractor climbed 11 positions in this market.
It now ranks #6 by positive obligations over the latest 12 months.
- Award net obligations
- $1.1M
- Share of 12-month positive obligations
- 2.7%
Supporting data
- Prime contractor
- #6 · 4.4% share
- up 11 ranks · +2.8 percentage points · $1.4M net increase; action accounted for 97.5%
This action
+$923K
DIASORIN INC
AMC BAMC FSH - MM
IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-25-P-A125 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026.
Why it stands out
The contractor climbed 7 positions in this market.
It now ranks #4 by positive obligations over the latest 12 months.
- Award net obligations
- $923K
- Share of 12-month positive obligations
- 1.8%
Supporting data
- Prime contractor
- #4 · 4.6% share
- up 7 ranks · +2.3 percentage points · $1.2M net increase; action accounted for 78.8%
This action
+$679K
BIO RAD LABORATORIES INC
AHC MONCRIEF JACKSON - MM
PATHOLOGY TESTING REQUIREMENT
Why it stands out
The contractor climbed 30 positions in this market.
It now ranks #15 by positive obligations over the latest 12 months.
- Award net obligations
- $719K
- Share of 12-month positive obligations
- 1.4%
Supporting data
- Prime contractor
- #15 · 2.3% share
- up 30 ranks · +1.9 percentage points · $966K net increase; action accounted for 70.2%
View recent award activity by date (10)
- Action+$54KAward net obligations$54K
- Action+$4KAward net obligations$4K
- Action+$655Award net obligations$655
- Action−$5KAward net obligations$517K
- Action+$5KAward net obligations$5K
- Action+$79Award net obligations$79
- Action+$23KAward net obligations$23K
- Action+$2KAward net obligations$2K
- Action−$247Award net obligations$134K
- Action+$183KAward net obligations$183K
DoD in-vitro diagnostic substance manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top DoD in-vitro diagnostic substance manufacturing contractors?
In the 12 months through September 10, 2026, ROCHE DIAGNOSTICS CORPORATION, HOLOGIC SALES AND SERVICE, LLC, and BECKMAN COULTER, INC were the leading DoD in-vitro diagnostic substance manufacturing prime contractors by positive obligations.
- #1
$7,680,534 in positive obligations
- #2
HOLOGIC SALES AND SERVICE, LLC
$3,483,135 in positive obligations
- #3
$2,528,806 in positive obligations
Rankings use reported USAspending award data.
Did DoD contract obligations increase in the in-vitro diagnostic substance manufacturing market?
Yes. Measured by net prime contract obligations, reported DoD activity in the in-vitro diagnostic substance manufacturing market increased 0.7% from $49,249,560 in the preceding 12 months to $49,583,598 in the 12 months through September 10, 2026.
- Latest 12 months
- $49,583,598
- Net prime contract obligations
- Preceding 12 months
- $49,249,560
- Net prime contract obligations
- Change
- +0.7%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent DoD contract award activity was reported in the in-vitro diagnostic substance manufacturing market?
Recent DoD contract award activity reported in the in-vitro diagnostic substance manufacturing market included actions for BECKMAN COULTER, INC, ABBOTT MOLECULAR INC., and ROCHE DIAGNOSTICS CORPORATION during the 12 months through September 10, 2026.
-
BECKMAN COULTER, INC · PIID W81K0025PA174
Modification P00002 · December 11, 2025 · Action obligation: +$1,493,318
-
ABBOTT MOLECULAR INC. · PIID W81K0025CA008
Modification P00001 · December 3, 2025 · Action obligation: +$1,521,794
-
ROCHE DIAGNOSTICS CORPORATION · PIID W81K0225FA154
Modification P00001 · December 16, 2025 · Action obligation: +$1,947,948
-
CEPHEID · PIID W81K0025FA081
Modification P00002 · December 8, 2025 · Action obligation: +$1,373,683
-
DIASORIN INC · PIID W81K0025PA125
Modification P00002 · December 17, 2025 · Action obligation: +$922,946
-
BIO RAD LABORATORIES INC · PIID W81K0025PA213
Modification P00001 · January 21, 2026 · Action obligation: +$678,811
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for DoD contracts under NAICS 325413?
From September 11, 2025 through September 10, 2026, DoD reported 473 positive-obligation awards for in-vitro diagnostic substance manufacturing under NAICS 325413. The leading award type was purchase order. The leading reported procedure was simplified acquisition.
- Positive-obligation awards
- 473
- Leading reported procedure
- Simplified Acquisition
- 75.7% of positive obligations
- Leading award type
- Purchase Order
- 49% of positive obligations
- Full and open
- 9.8%
- of positive obligations
- Reported parent IDV
- 38.8%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.
Review data methodology